NFG
BMRN icon

Next Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Next Financial Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$98K Buy
1,113
+58
+5% +$4.79K 0.01% 1173
2021
Q3 		$81K Buy
1,055
+28
+3% +$2.21K 0.01% 1207
2021
Q2 		$85K Buy
1,027
+11
+1% +$872 0.01% 1188
2021
Q1 		$77K Buy
+1,016
New +$83K 0.01% 1117
2020
Q2 		– Sell
-200
Closed -$17K – 755
2020
Q1 		$17K Hold
200
– – ﹤0.01% 1332
2019
Q4 		$17K Hold
200
– – ﹤0.01% 1578
2019
Q3 		$13K Hold
200
– – ﹤0.01% 1597
2019
Q2 		$17K Buy
+200
New +$17.1K ﹤0.01% 1513
2019
Q1 		– Sell
-132
Closed -$11K – 1668
2018
Q4 		$11K Sell
132
-293
-69% -$27.9K ﹤0.01% 1297
2018
Q3 		$41K Buy
+425
New +$42.4K 0.02% 588
2017
Q4 		– Sell
-1,740
Closed -$166K – 386
2017
Q3 		$166K Sell
1,740
-1,285
-42% -$114K 0.05% 361
2017
Q2 		$275K Sell
3,025
-25
-0.8% -$2.27K 0.07% 281
2017
Q1 		$292K Sell
3,050
-275
-8% -$24.5K 0.08% 241
2016
Q4 		$275K Buy
3,325
+350
+12% +$30.1K 0.05% 373
2016
Q3 		$275K Buy
2,975
+995
+50% +$93.7K 0.05% 372
2016
Q2 		$154K Buy
1,980
+1,405
+244% +$119K 0.05% 358
2016
Q1 		$47K Buy
575
+375
+188% +$30.5K 0.02% 640
2015
Q4 		$20K Hold
200
– – 0.01% 910
2015
Q3 		$21K Hold
200
– – 0.01% 926
2015
Q2 		$27K Hold
200
– – 0.01% 876
2015
Q1 		$24K Buy
200
+50
+33% +$5.3K 0.01% 918
2014
Q4 		$14K Sell
150
-50
-25% -$4.16K ﹤0.01% 1115
2014
Q3 		$14K Sell
200
-68
-25% -$4.47K ﹤0.01% 1593
2014
Q2 		$17K Buy
+268
New +$16.2K 0.01% 641

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Next Financial Group's BMRN Position: Q4 2021 in Review

Next Financial Group increased its BioMarin Pharmaceuticals (BMRN) stake by 5.5% in Q4 2021, buying an estimated $4.79K and bringing the position to 1,113 shares worth $98K. The position accounts for 0.01% of the portfolio, ranked #1173.

Next Financial Group first reported a position in BMRN in Q2 2014 and has held it in 24 quarters since. The position peaked at $292K in Q1 2017. 556 funds tracked by Wall St. Rank hold BMRN as of Q4 2021.

  • Next Financial Group held 1,113 shares of BioMarin Pharmaceuticals worth $98K as of Q4 2021.
  • Next Financial Group bought 58 BioMarin Pharmaceuticals shares in Q4 2021, an estimated $4.79K.
  • BioMarin Pharmaceuticals made up 0.01% of Next Financial Group's portfolio in Q4 2021, its #1173 holding.
  • Next Financial Group first reported a position in BioMarin Pharmaceuticals in Q2 2014 and has held it in 24 quarters since.
  • Next Financial Group's BioMarin Pharmaceuticals position peaked at $292K in Q1 2017.
  • 556 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.